Israel Englander’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $700K | Sell |
133,305
-23,852
| -15% | -$120K | ﹤0.01% | 4554 |
|
|
2026
Q1 | $585K | Sell |
157,157
-94,548
| -38% | -$653K | ﹤0.01% | 4680 |
|
|
2025
Q4 | $2.06M | Buy |
251,705
+116,500
| +86% | +$862K | ﹤0.01% | 3926 |
|
|
2025
Q3 | $995K | Buy |
135,205
+67,456
| +100% | +$510K | ﹤0.01% | 4631 |
|
|
2025
Q2 | $550K | Sell |
67,749
-33,064
| -33% | -$223K | ﹤0.01% | 4841 |
|
|
2025
Q1 | $710K | Buy |
+100,813
| New | +$627K | ﹤0.01% | 4597 |
|
|
2024
Q2 | – | Sell |
-352,707
| Closed | -$1.87M | – | 6259 |
|
|
2024
Q1 | $1.87M | Buy |
352,707
+88,719
| +34% | +$635K | ﹤0.01% | 3805 |
|
|
2023
Q4 | $1.63M | Sell |
263,988
-349,299
| -57% | -$2.43M | ﹤0.01% | 3773 |
|
|
2023
Q3 | $4.63M | Buy |
613,287
+237,665
| +63% | +$2.17M | ﹤0.01% | 2770 |
|
|
2023
Q2 | $3.63M | Buy |
+375,622
| New | +$2.29M | ﹤0.01% | 2947 |
|
|
2023
Q1 | – | Sell |
-40,036
| Closed | -$259K | – | 6625 |
|
|
2022
Q4 | $259K | Buy |
40,036
+19,371
| +94% | +$160K | ﹤0.01% | 5183 |
|
|
2022
Q3 | $184K | Buy |
20,665
+32
| +0.2% | +$325 | ﹤0.01% | 5702 |
|
|
2022
Q2 | $206K | Sell |
20,633
-17,158
| -45% | -$170K | ﹤0.01% | 5624 |
|
|
2022
Q1 | $438K | Buy |
37,791
+26,802
| +244% | +$298K | ﹤0.01% | 5229 |
|
|
2021
Q4 | $122K | Sell |
10,989
-87,928
| -89% | -$853K | ﹤0.01% | 6178 |
|
|
2021
Q3 | $912K | Buy |
98,917
+26,039
| +36% | +$283K | ﹤0.01% | 4791 |
|
|
2021
Q2 | $820K | Sell |
72,878
-18,209
| -20% | -$210K | ﹤0.01% | 4857 |
|
|
2021
Q1 | $966K | Sell |
91,087
-37,928
| -29% | -$426K | ﹤0.01% | 4249 |
|
|
2020
Q4 | $1.4M | Buy |
129,015
+49,267
| +62% | +$509K | ﹤0.01% | 3497 |
|
|
2020
Q3 | $775 | Buy |
79,748
+45,445
| +132% | +$433K | ﹤0.01% | 3313 |
|
|
2020
Q2 | $273K | Sell |
34,303
-60,417
| -64% | -$623K | ﹤0.01% | 3711 |
|
|
2020
Q1 | $823K | Buy |
+94,720
| New | +$986K | ﹤0.01% | 2590 |
|
|
2019
Q3 | – | Sell |
-16,786
| Closed | -$157K | – | 4381 |
|
|
2019
Q2 | $157K | Sell |
16,786
-23,885
| -59% | -$241K | ﹤0.01% | 3816 |
|
|
2019
Q1 | $499K | Buy |
+40,671
| New | +$497K | ﹤0.01% | 3270 |
|
|
2015
Q4 | – | Sell |
-57,670
| Closed | -$673K | – | 3610 |
|
|
2015
Q3 | $673K | Buy |
57,670
+24,447
| +74% | +$324K | ﹤0.01% | 2498 |
|
|
2015
Q2 | $479K | Buy |
+33,223
| New | +$479K | ﹤0.01% | 2655 |
|
|
2015
Q1 | – | Sell |
-20,660
| Closed | -$285K | – | 3873 |
|
|
2014
Q4 | $285K | Buy |
20,660
+2,496
| +14% | +$32.3K | ﹤0.01% | 3385 |
|
|
2014
Q3 | $223K | Buy |
+18,164
| New | +$227K | ﹤0.01% | 3341 |
|
|
2013
Q4 | – | Sell |
-78,940
| Closed | -$963K | – | 3615 |
|
|
2013
Q3 | $963K | Buy |
78,940
+19,582
| +33% | +$273K | ﹤0.01% | 2132 |
|
|
2013
Q2 | $784K | Buy |
+59,358
| New | +$821K | ﹤0.01% | 2085 |
|
Other funds holding LFCR
WC
LPAM
GRIM
3C
QOP
Israel Englander's LFCR Position: Q2 2026 in Review
Israel Englander reduced its Lifecore Biomedical (LFCR) stake by 15% in Q2 2026, selling an estimated $120K and leaving 133,305 shares worth $700K. The position accounts for ﹤0.01% of the portfolio, ranked #4554.
Israel Englander first reported a position in LFCR in Q2 2013 and has held it in 30 quarters since. The position peaked at $4.63M in Q3 2023. 98 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.
- Israel Englander held 133,305 shares of Lifecore Biomedical worth $700K as of Q2 2026.
- Israel Englander sold 23,852 Lifecore Biomedical shares in Q2 2026, an estimated $120K.
- Lifecore Biomedical made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #4554 holding.
- Israel Englander first reported a position in Lifecore Biomedical in Q2 2013 and has held it in 30 quarters since.
- Israel Englander's Lifecore Biomedical position peaked at $4.63M in Q3 2023.
- 98 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.